Dj%252525252525252525252520citral

# Citral (3,7-Dimethyl-2,6-octadienal) ## Overview Citral is an acyclic monoterpene aldehyde, primarily used as a flavoring agent and fragrance component in cosmetic and pharmaceutical preparations. It is typically derived from lemongrass (*Cymbopogon*) or synthesized. It possesses documented *in vitro* anti-inflammatory, antimicrobial, and antioxidant properties, though clinical systemic therapeutic use is limited. ## Primary Indications Primarily used as a pharmaceutical excipient (flavoring/masking agent). Investigational uses include topical treatment for fungal infections or as a carminative. There are no FDA-approved systemic indications for citral as an active pharmaceutical ingredient. ## Adult Dosing No standard therapeutic dosing exists. Doses are determined by manufacturer specifications for topical/flavoring applications. * **Safety Threshold:** The Research Institute for Fragrance Materials (RIFM) suggests a maximum concentration of 0.6% in leave-on skin products to avoid sensitization. ## Pediatric Dosing No established pediatric dosage exists. Use is limited to excipient concentrations in commercial products. ## Dose Adjustments No specific guidelines for hepatic or renal impairment; however, excessive ingestion should be avoided. ## Contraindications * Known hypersensitivity or contact allergy to citral. * Individuals with a history of severe contact dermatitis or eczema. ## Adverse Effects * **Dermatologic:** Strong cutaneous sensitizer. Frequent cause of allergic contact dermatitis. May cause erythema, pruritus, or vesicular eruptions upon repeated topical exposure. * **Ocular/Respiratory:** Irritation to mucous membranes if inhaled or applied near eyes as a concentrated vapor. * **Systemic:** Generally recognized as safe (GRAS) by the FDA for food-grade ingestion at current commercial levels; however, high oral doses in animal models have indicated potential for gastric irritation. ## Key Drug Interactions No clinically significant systemic drug-drug interactions documented. Theoretically, it may affect the absorption of other topical agents due to its potential as a skin penetration enhancer. ## Monitoring * Monitor for signs of contact dermatitis (rash, persistent redness, burning) with prolonged topical use. * No systemic laboratory monitoring required. ## Clinical Pearls * **Sensitization Risk:** Citral is a known allergen. Cross-reactivity may occur with eugenol or geraniol. * **Stability:** It is highly prone to oxidation; stored products containing citral should be kept in airtight, light-resistant containers. * **Regulatory:** It is on the "Fragrance Allergens" list regulated by the EU Cosmetic Regulation 1223/2009, requiring mandatory labeling on products if concentrations exceed 0.001% in leave-on products or 0.01% in rinse-off products. *** **Educational Disclaimer:** This information is for educational purposes only. Citral is not an FDA-approved drug for systemic disease treatment. Medication protocols and safety profiles change; always verify current prescribing information, local clinical guidelines, and package inserts before clinical use.